SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells

FEBS Lett. 2000 Feb 4;467(1):12-6. doi: 10.1016/s0014-5793(00)01099-1.

Abstract

Brugada syndrome is a hereditary cardiac disease causing abnormal ST segment elevation in the ECG, right bundle branch block, ventricular fibrillation and sudden death. In this study we characterized a new mutation in the SCN5A gene (T1620M), causing the Brugada syndrome. The mutated channels were expressed in both Xenopus leavis oocytes and in mammalian tsA201 cells with and without the beta-subunit and studied using the patch clamp technique. Opposite phenotypes were observed depending on the expression system. T1620M mutation led to a faster recovery from inactivation and a shift of steady-state inactivation to more positive voltages when expressed in Xenopus oocytes. However, using the mammalian expression system no effect on steady-state inactivation was observed, but this mutation led to a slower recovery from inactivation. Our finding supports the idea that the slower recovery from inactivation of the cardiac sodium channels seen in our mammalian expression system could decrease the density of sodium channels during the cardiac cycle explaining the in vivo arrhythmogenesis in patients with Brugada syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution / genetics*
  • Animals
  • Cell Line
  • Electric Conductivity
  • Gene Expression
  • Humans
  • Kinetics
  • Mutation / genetics*
  • Myocardium
  • NAV1.5 Voltage-Gated Sodium Channel
  • Oocytes / metabolism
  • Patch-Clamp Techniques
  • Phenotype
  • Sodium / metabolism
  • Sodium Channels / chemistry
  • Sodium Channels / genetics*
  • Sodium Channels / metabolism*
  • Syndrome
  • Ventricular Fibrillation / congenital*
  • Ventricular Fibrillation / genetics*
  • Xenopus laevis

Substances

  • NAV1.5 Voltage-Gated Sodium Channel
  • SCN5A protein, human
  • Sodium Channels
  • Sodium